SCHEMBL18522286

SCHEMBL18522286

CCOC(=O)c1noc(-c2cc(OC)ncc2F)c1SC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 2/20 0.39
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
HTT P42858 2/20 0.35
JMJD6 Q6NYC1 2/20 0.33
FFAR4 Q5NUL3 1/20 0.33
NNMT P40261 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NAMPT P43490 1/20 0.33
ATM Q13315 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
AAK1 Q2M2I8 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MLYCD O95822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18501528 0.87 TDP2 (0.41) TDP2LMNATHRBHTTJMJD6
SCHEMBL18490201 0.86 TDP2 (0.40) TDP2LMNATHRBHTTJMJD6
SCHEMBL18511704 0.85 TDP2 (0.40) TDP2LMNATHRBHTTJMJD6
SCHEMBL18490255 0.82 TDP2 (0.37) TDP2LMNATHRBHTTJMJD6
SCHEMBL18490194 0.79 TDP2 (0.39) TDP2LMNAHTTALDH1A1L3MBTL1
SCHEMBL18492272 0.79 TDP2 (0.37) TDP2LMNATHRBHTTFFAR4
SCHEMBL18490152 0.68 PRKCZ (0.43) TDP2HTTALDH1A1NPC1KDM4E
SCHEMBL18490109 0.67 EED (0.40) TDP2LMNATHRBALDH1A1KDM4E
SCHEMBL18501529 0.67 TDP2 (0.41) TDP2LMNATHRBHTTALDH1A1
SCHEMBL18501532 0.66 TDP2 (0.42) TDP2LMNATHRBHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017027310-A1 GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2017-02-16 WO disclosed